Offer - Urjas Oil for just ₹ 1
Novoroid 25 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of Hypothyroidism. The alternative uses of Novoroid 25 Tablet have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Novoroid 25 Tablet. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Novoroid 25 Tablet can also lead to other problems, which have been listed below. Such side effects of Novoroid 25 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Novoroid 25 Tablet has a Safe effect for pregnant women and Mild effect on lactating mothers. In addition, Novoroid 25 Tablet's effects on the liver, heart and kidney are discussed below in the Novoroid 25 Tablet related warnings section.
Novoroid 25 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Novoroid 25 Tablet in conditions like Heart Disease, Hypopituitarism. Other contraindications of Novoroid 25 Tablet have been discussed in the sections ahead.
Additionally, Novoroid 25 Tablet may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Novoroid 25 Tablet is safe while driving, and is is addictive in nature.
Novoroid 25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
Based on research, the following side effects have been observed when Novoroid 25 Tablet is used -
Is the use of Novoroid 25 Tablet safe for pregnant women?
Novoroid is safe to take during pregnancy.
Is the use of Novoroid 25 Tablet safe during breastfeeding?
Breastfeeding women can take Novoroid as it bears very minor side effects for them.
What is the effect of Novoroid 25 Tablet on the Kidneys?
Novoroid is not harmful for kidneys.
What is the effect of Novoroid 25 Tablet on the Liver?
Novoroid is completely safe for the liver.
What is the effect of Novoroid 25 Tablet on the Heart?
Novoroid is completely safe for the heart.
Novoroid 25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Novoroid 25 Tablet unless your doctor advises you to do so -
Is this Novoroid 25 Tablet habit forming or addictive?
Forming a habit of Novoroid 25 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Novoroid 25 Tablet since it does not cause drowsiness.
Is it safe?
Novoroid 25 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Novoroid 25 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Novoroid 25 Tablet
You can take Novoroid 25 Tablet with food.
Interaction between Alcohol and Novoroid 25 Tablet
Information about the interaction of Novoroid 25 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levoxyl (levothyroxine sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 769-770
